SAFER™

Accurate testing is dependent on sampling quality and not the least, sample integrity. Proper storage and transport conditions ensure that samples remain viable for testing upon reaching the testing laboratory.

SAFER™ features a proprietary formula of transport medium that inactivates and preserves viral ribonucleic acids (RNA) at room temperature (15 – 30 °C) for up to a week, without the need for chilling. This removes the constraint of strict shipping conditions at low temperatures which may not be readily available. SAFER™ makes testing possible and more convenient to previously inaccessible areas, expanding the reach of healthcare.

The SAFER™ Stabilization Fluid also inactivates the SARS-CoV-2 virus within 45 seconds, without the use of guanidine, making specimen collection safer and less risky for healthcare personnel and the community.

Benefits
  • Proven to inactivate SARS-CoV-2 virus within 45 seconds.
  • Stabilization and preservation of viral RNA at Room Temperature (15 – 30 °C), up to a week.
  • Easy collection and transport of samples.
  • Compatible with qPCR tests.
  • Non-invasive specimen collection.
Catalogue No. Description
SAFER-SAL-01-B SAFER™ Total (For saliva/ sputum specimen collection)
– 2mL SAFER™ Stabilization Fluid /vial, a Funnel Collection Tube, and a Top Cap in a Clamshell Protective Case.
– Includes necessary packaging for triple bag protocol that keeps sample upright.
SAFER-SAL-01-P SAFER™ Clinic (For saliva/ sputum specimen collection)
– 2mL SAFER™ Stabilization Fluid /vial, with a Funnel Collection Tube, and a Top Cap in a sealed pouch
SAFER-SAL-01-E SAFER™ Eco (For saliva/ sputum specimen collection)
– 2mL SAFER™ Stabilization Fluid /vial only for saliva/ sputum specimen collection.
SAFER-VTM-01 SAFER™ VTM (For use with nasopharyngeal (NP) and oropharyngeal (OP) swabs)
– 3mL SAFER™ Stabilization Fluid /vial only

Clinical Validation

 

SAFER™ participated in the Singapore-based COVID-19 specimen-sensitivity study, which was cited as the world’s 2nd largest trial size in 2020. The study aimed to compare the sensitivity of nasopharyngeal swabs (NP), nasal swabs (NS), andnaso-oropharyngeal (NOP) saliva in a large cohort of migrant workers in Singapore.

 

Saliva-based collection using SAFER™ returned 36% more positive results as
compared to the existing gold standard of nasopharyngeal swabs.

 

 

Read more

Technical Specifications

 

Application Reverse Transcription qPCR
Device Specifications Viral Transport Medium
Storage Conditions 15 – 30 °C (59 – 86 °F)
Sample Type Saliva
Sample Stability 15 – 30 °C (59 – 86 °F) ≤ 1 week
Shelf Life Available upon request

 

SAFER™ is registered with the Health Sciences Authority (HSA) of Singapore as a Class A medical device.
Users are advised to consult with local regulatory authorities for appropriate use. Terms and conditions apply.

 



Need Help?